{
    "Trade/Device Name(s)": [
        "QuickVue\u00ae Influenza test"
    ],
    "Submitter Information": "Quidel Corporation",
    "510(k) Number": "K131599",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "GNX"
    ],
    "Summary Letter Date": "July 5, 2013",
    "Summary Letter Received Date": "June 5, 2013",
    "Submission Date": "May 30, 2013",
    "Regulation Number(s)": [
        "21 CFR 866.3330"
    ],
    "Regulation Name(s)": [
        "Influenza virus serological reagents"
    ],
    "Analyte Class(es)": [
        "virology"
    ],
    "Analyte(s)": [
        "Influenza A antigen",
        "Influenza B antigen"
    ],
    "Specimen Type(s)": [
        "Nasal swab",
        "Nasal aspirate",
        "Nasal wash"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay"
    ],
    "Methodologies": [
        "Qualitative detection",
        "Visual readout"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for Quidel QuickVue Influenza rapid immunochromatographic test for qualitative detection of influenza A and B antigens in nasal specimens.",
    "Indications for Use Summary": "Rapid, qualitative detection of influenza type A and B antigens from nasal swab, nasal aspirate, and nasal wash specimens to aid in the diagnosis of acute influenza virus infection, for professional and laboratory use.",
    "fda_folder": "Microbiology"
}